Phase 3 Readout~month
Phase 3 Topline: SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of QTORIN
- Drug
- qtorin
- Indication
- Microcystic Lymphatic Malformation
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.